Clinical Trial Update: Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update: a dose-finding study of a DNA vaccine delivered by intradermal electroporation in prostate cancer patients has completed Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DNA vaccine (intradermal electroporation) (DNA vaccine)

Snippet

Sponsor: Uppsala University | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED